Home
Our Business
SPI’s Strengths
About Us
Notifications

Bioresource Materials矢印

Bio Research Instruments and Reagents矢印

Drug discovery partnering support矢印

EN
2025.04.28

Summit Pharmaceuticals International Corporation Celebrates 40th Anniversary as ATCC’s distributor in Japan

Summit Pharmaceuticals International Corporation (Headquarters: Chiyoda-ku, Tokyo, President & CEO: Katsuya Okuyama, hereinafter “SPI”) celebrates its 40th anniversary as the Japanese distributor for the American Type Culture Collection (ATCC) in 2025.

 

On March 17, 2025, ATCC’s CEO visited SPI and presented a commemorative plaque for the 40th anniversary.

 

ATCC, the world’s largest biorepository, provides over 90,000 biological resources, contributing to pharmaceutical research and development. SPI became the official distributor for ATCC in 1985 and has since been providing high-quality biological resources to Japanese research institutions and companies. Notably, 2025 also marks ATCC’s 100th anniversary. SPI and ATCC aim to continue contributing to the life sciences field, including drug discovery research.

 

SPI, a wholly owned subsidiary of Sumitomo Corporation, plays a central role in the company’s pharmaceutical business. Utilizing its global network and pharmaceutical expertise, SPI provides comprehensive support for pharmaceutical-related businesses, from drug discovery research to pharmaceutical production.

 

Presentation of the commemorative plaque

 

 

 

 

 

 

Exterior view of ATCC headquarters

 

 

 

 

 

 

[Contact]
Summit Pharmaceuticals International Corporation
Bio Resource Group
Discovery Alliance Coordination Dept.
Email:atcc@summitpharma.co.jp